The accumulation of the small 42‐residue long peptide amyloid‐β (Aβ) has been proposed
as a major trigger for the development of Alzheimer's disease (AD). Within the brain, the …

Neurodegenerative disorders are characterized by complex multifactorial pathogeneses,
thus posing a challenge for standard therapeutic approaches that tend to focus only on one …

Microglia have an innate immunity memory (IIM) with divergent functions in different animal
models of neurodegenerative diseases, including Alzheimer's disease (AD). AD is …

Alzheimer's disease (AD) is characterised by the aggregation and deposition of amyloid-β
(Aβ) peptides in the human brain. In age-related late-onset AD, deficient degradation and …

OBJECTIVE: It has been increasingly recognized that the pathological progress of
Alzheimers disease (AD) is connected to metabolic function and inflammation. Insulin …

Parkinson's disease (PD) in military personnel engaged in combat operations is likely to
develop in their later lives. In order to enhance the quality of lives of PD patients, exploration …

Résumé Les maladies neurodégénératives se caractérisent par des accumulations
anormales de protéines spécifiques dans le cerveau qui sont associées à la perte de …

The number of individuals with diabetes worldwide has quadrupled since 1980, making
diabetes the 4th most common cause of death from non-communicable disease. Since …

Background: Prior research has demonstrated an elevated risk of Alzheimer's disease (AD)
among individuals diagnosed with type 2 diabetes mellitus (T2DM). Insulin resistance is a …

Neurodegenerative disorders are characterized by complex multifactorial pathogeneses,
thus posing a challenge for standard therapeutic approaches that tend to focus only on one …